Centre Hospitalier De Haguenau

At Centre Hospitalier De Haguenau, clinical research in cardiovascular diseases focuses on major conditions such as acute myocardial infarction, acute coronary syndrome, atrial fibrillation, and broader heart and blood vessel disease. These studies are designed to test new treatment strategies, improve prevention of complications, and evaluate ways to lower the risk of death or hospital admission.

• New approaches for reducing cardiovascular risk after heart attacks and coronary interventions
• Studies in patients with advanced chronic kidney disease and elevated cardiovascular risk
• Research on antithrombotic treatment strategies for atrial fibrillation and stent-related care

Research in this area also includes treatment personalization for people with combined cardiovascular and metabolic risk factors, aiming to make care safer and more effective.

The intensive care department is actively involved in studies on sepsis, critical illness-related corticosteroid insufficiency, and septic cardiomyopathy. These trials explore better ways to support patients with severe infection and organ failure, with the goal of improving recovery and survival in the ICU.

• Testing treatments for septic shock and organ dysfunction
• Evaluating steroid-based strategies in critically ill patients
• Personalizing care for patients with different immune and inflammatory profiles

This line of research supports better decisions in intensive care by looking for therapies that may reduce dependence on life-support treatments and improve longer-term outcomes.

Clinical trials in respiratory tract diseases at this site include work on acute respiratory failure and the management of patients receiving high-flow nasal oxygen therapy. The purpose of these studies is to improve breathing support, guide safer weaning from respiratory assistance, and strengthen ICU care for patients with serious lung problems.

• Improving recovery from acute respiratory failure
• Testing structured approaches to stopping oxygen support
• Supporting better outcomes for critically ill patients with breathing difficulties

These studies reflect a practical focus on making respiratory treatment more effective and easier to tailor to each patient’s condition.

Research in infectious diseases at Centre Hospitalier De Haguenau includes trials in sepsis and severe infection among ICU patients. The main goal is to improve recognition of infection-related complications and evaluate therapies that may better control inflammation, support organ function, and reduce the impact of life-threatening infections.

• Studies in patients admitted to the ICU with suspected or confirmed infection
• Research on treatment responses in sepsis
• Work aimed at improving personalized management of severe infection

This area combines infection care with critical care medicine, helping clinicians refine treatment for patients facing complex infectious illnesses.

Some trials at the site address mixed or broader clinical questions that do not fit neatly into a single disease category. These studies often focus on improving overall treatment effectiveness, safety, or decision-making in complex hospital patients.

• Evaluating new ways to reduce major cardiovascular and organ-related events
• Exploring treatment strategies for patients with multiple serious conditions
• Generating evidence to guide everyday clinical care in hospital settings

Across these projects, the hospital contributes to research that aims to make care more precise, safer, and better adapted to real-world patient needs.